Table 2 Recent published series of patients with pancreatic metastases
From: Diagnosis and treatment of pancreatic metastases in 22 patients: a retrospective study
Author, year | Number of patients | Metastasis from lung cancer | Metastasis from renal cancer | Metastasis from gastric cancer | Incidence | Interval (month) | Symptoms at diagnosis | Synchronous metastasis | Survival (months) | |
|---|---|---|---|---|---|---|---|---|---|---|
2 year | 5 year | |||||||||
Present study | 22 | 2 (9.1% ) | 1 (4.5%) | 7 (31.8%) | 2% | 55 (1 to 92) | 18 (81.8%) | 2 (9.1% ) | 35.3% | 11.8% |
Markinez [20], 2013 | 8 | 0 | 8 (100%) | 0 | 1.2% | 149 (19 to 361) | NR | 3 (37.5%) | 37.5% | 12.5% |
Boo SJ [21], 2011 | 31 | 9 (29%) | 16 (51.6%) | 1 (3.2%) | NR | 40.8 (3 to 186) | NR | 6 (19.4%) | NR | NR |
Reddy S [17], 2008 | 49 | 4 (8.2%) | 21 (42.9%) | 0 | NR | 4.8 | 45 (92%) | 7 (14%) | NR | NR |
Zerbi A [22], 2008 | 36 | 0 | 36 (100%) | 0 | NR | 8 | 8 (22%) | 0 | 95% | 88% |
Sellner F [13], 2006 | 236 | 0 | 236 (100%) | 0 | NR | 10 | 66 (65%) | 23 (12%) | 78% | 72% |
Xu DK [5], 2006 | 18 | 8 (44.4%) | 1 (5.6%) | 2 (11.1%) | 15% | 12 (3 to 216) | NR | 4 (22.2%) | NR | NR |